|
Clinical characteristics
|
N
|
NovelmiRNA-25
|
P
|
all-hsa-miR-1273h-5p
|
P
|
|---|
|
Leukocyte
|
|
< 3.5
|
2
|
0.39 ± 0.12
|
0.045
|
1.50 ± 0.67
|
0.452
|
|
3.5–9.5
|
16
|
5.80 ± 5.38
|
2.78 ± 2.00
|
|
> 9.5
|
3
|
0.64 ± 0.25
|
1.89 ± 1.02
|
|
Neutrophil
|
|
1.8–6.3
|
15
|
6.06 ± 5.48
|
0.002
|
2.91 ± 2.01
|
0.271
|
|
> 6.3
|
4
|
0.78 ± 0.34
|
1.72 ± 0.90
|
|
Albumin
|
|
< 40
|
14
|
4.89 ± 4.85
|
0.034
|
2.98 ± 1.98
|
0.748
|
|
40–55
|
1
|
16.81
|
3.65
|
|
C3
|
|
< 0.79
|
15
|
5.67 ± 5.74
|
0.019
|
2.86 ± 2.04
|
0.173
|
|
0.79–1.52
|
7
|
1.55 ± 1.61
|
1.73 ± 0.72
|
|
C4
|
|
< 0.16
|
17
|
4.68 ± 5.76
|
0.524
|
1.75 (1.15, 2.57)
|
0.031
|
|
0.16–0.38
|
4
|
2.74 ± 2.12
|
3.91 (2.45, 6.17)
|
|
Lupus anticoagulant
|
|
0.75–1.25
|
10
|
3.65 ± 5.57
|
0.561
|
2.11 ± 1.24
|
0.034
|
|
> 1.25
|
3
|
5.62 ± 4.57
|
4.58 ± 2.50
|
|
24 h urine protein
|
|
< 0.5
|
3
|
8.65 ± 8.17
|
0.074
|
4.36 ± 2.80
|
0.073
|
|
> 0.5
|
9
|
2.80 ± 2.73
|
2.11 ± 1.25
|
|
Alanine aminotransferase
|
|
7–40
|
14
|
5.36 ± 5.96
|
0.984
|
2.79 ± 1.98
|
0.61
|
|
> 40
|
2
|
5.45 ± 0.03
|
3.57 ± 1.96
|
|
Anti-ds-DNA antibody
|
|
Positive
|
12
|
1.99 (0.53, 6.59)
|
0.75
|
1.64 (1.07, 4.62)
|
0.553
|
|
Negative
|
6
|
2.10 (0.73, 11.75)
|
1.64 (1.07, 4.62)
|
- C3/C4 complement 3/complement 4
